Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing

被引:263
|
作者
Zhang, Song [1 ]
Shen, Jiangtao [2 ]
Li, Dali [3 ]
Cheng, Yiyun [1 ,3 ]
机构
[1] South China Univ Technol, Sch Mol Sci & Engn, South China Adv Inst Soft Matter Sci & Technol, Guangzhou 510640, Peoples R China
[2] Yangzhou Univ, Peoples Hosp Taizhou 2, Taizhou 225500, Peoples R China
[3] East China Normal Univ, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China
来源
THERANOSTICS | 2021年 / 11卷 / 02期
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
genome editing; CRISPR; RNP; polymers; nanoparticles; SPHERICAL NUCLEIC-ACIDS; BLACK PHOSPHORUS NANOSHEETS; HOMOLOGY-DIRECTED REPAIR; EFFICIENT DELIVERY; PROTEIN DELIVERY; IN-VITRO; EXTRACELLULAR VESICLES; NANOPARTICLE DELIVERY; INTRACELLULAR PROTEIN; MEDIATED DELIVERY;
D O I
10.7150/thno.47007
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
CRISPR/Cas9 genome editing has gained rapidly increasing attentions in recent years, however, the translation of this biotechnology into therapy has been hindered by efficient delivery of CRISPR/Cas9 materials into target cells. Direct delivery of CRISPR/Cas9 system as a ribonucleoprotein (RNP) complex consisting of Cas9 protein and single guide RNA (sgRNA) has emerged as a powerful and widespread method for genome editing due to its advantages of transient genome editing and reduced off-target effects. In this review, we summarized the current Cas9 RNP delivery systems including physical approaches and synthetic carriers. The mechanisms and beneficial roles of these strategies in intracellular Cas9 RNP delivery were reviewed. Examples in the development of stimuli-responsive and targeted carriers for RNP delivery are highlighted. Finally, the challenges of current Cas9 RNP delivery systems and perspectives in rational design of next generation materials for this promising field will be discussed.
引用
收藏
页码:614 / 648
页数:35
相关论文
共 50 条
  • [41] CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications
    Cheng, Hao
    Zhang, Feng
    Ding, Yang
    PHARMACEUTICS, 2021, 13 (10)
  • [42] Recent Advances in CRISPR/Cas9 Delivery Strategies
    Yip, Bon Ham
    BIOMOLECULES, 2020, 10 (06)
  • [43] Efficient Editing of an Adenoviral Vector Genome with CRISPR/Cas9
    Li, Qiang
    Wang, Hui
    Gong, Chen-yu
    Chen, Zhao
    Yang, Jia-xing
    Shao, Hong-wei
    Zhang, Wen-feng
    INDIAN JOURNAL OF MICROBIOLOGY, 2021, 61 (01) : 91 - 95
  • [44] CRISPR/Cas9 genome editing through in planta transformation
    Zlobin, Nikolay E.
    Lebedeva, Marina V.
    Taranov, Vasiliy V.
    CRITICAL REVIEWS IN BIOTECHNOLOGY, 2020, 40 (02) : 153 - 168
  • [45] CRISPR/Cas9 for genome editing: progress, implications and challenges
    Zhang, Feng
    Wen, Yan
    Guo, Xiong
    HUMAN MOLECULAR GENETICS, 2014, 23 : R40 - R46
  • [46] Genome editing of Clostridium autoethanogenum using CRISPR/Cas9
    Nagaraju, Shilpa
    Davies, Naomi Kathleen
    Walker, David Jeffrey Fraser
    Kopke, Michael
    Simpson, Sean Dennis
    BIOTECHNOLOGY FOR BIOFUELS, 2016, 9
  • [47] CRISPR/Cas9 genome editing of RDEB mutation hotspot
    Naso, G.
    Petrova, A.
    Qasim, W.
    HUMAN GENE THERAPY, 2019, 30 (02) : A8 - A8
  • [48] Recent Advances in Genome Editing Using CRISPR/Cas9
    Ding, Yuduan
    Li, Hong
    Chen, Ling-Ling
    Xie, Kabin
    FRONTIERS IN PLANT SCIENCE, 2016, 7
  • [49] Editing the genome of Aphanomyces invadans using CRISPR/Cas9
    Majeed, Muhammad
    Soliman, Hatem
    Kumar, Gokhlesh
    El-Matbouli, Mansour
    Saleh, Mona
    PARASITES & VECTORS, 2018, 11
  • [50] Application of CRISPR/Cas9 Nuclease in Amphioxus Genome Editing
    Su, Liuru
    Shi, Chenggang
    Huang, Xin
    Wang, Yiquan
    Li, Guang
    GENES, 2020, 11 (11) : 1 - 9